ACE2 and nonpapillary renal cell carcinoma: Furthermore, serum activity of NEP/CD10, ACE2 and APA is higher in RCC patients than in healthy subjects and ACE and NEP/CD10 activity is negatively correlated with CCRCC patients’ prognosis.